NCT00524563
- Conditions
- Acinetobacter Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
- Locations
-
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
Gram-Negative Bacterial Infections
Explore clinical trials studying Gram-Negative Bacterial Infections. Study availability and eligibility vary by location and protocol.
1,462 public trials
132 recruiting studies
Gram-Negative Bacterial Infections trial results
NCT00462579
- Conditions
- Acinetobacter Infections, Bacterial Infections, Bacterial Infections and Mycoses, +3 more
- Locations
-
- UPMC Pittsburgh, Pennsylvania, United States
Completed
Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects
NCT00464815
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Goā, India
- GSK Investigational Site Indore, India
- GSK Investigational Site New Delhi, India
- GSK Investigational Site Pune, India
NCT00454909
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Daly City, California, United States
- GSK Investigational Site Fairfield, California, United States
- GSK Investigational Site Redwood City, California, United States
- GSK Investigational Site Sacramento, California, United States
NCT00465816
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Aarhus N, Denmark
- GSK Investigational Site Karlskrona, Sweden
- GSK Investigational Site Linköping, Sweden
- GSK Investigational Site Malmö, Sweden
NCT00290329
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Alabang, Muntinlupa City, Philippines
- GSK Investigational Site Binangonan, Rizal, Philippines
- GSK Investigational Site Cainta, Rizal, Philippines
- GSK Investigational Site City of Muntinlupa, Philippines
NCT00196976
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
- GSK Investigational Site Eferding, Austria
- GSK Investigational Site Graz, Austria
- GSK Investigational Site Salzburg, Austria
- GSK Investigational Site Vienna, Austria
NCT01086423
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China
- GSK Investigational Site Wuzhou, Guangxi, China
NCT00169442
- Conditions
- Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
- Locations
-
- GSK Investigational Site City of Muntinlupa, Philippines
- GSK Investigational Site Pasay, Philippines
- GSK Investigational Site Quezon City, Philippines
NCT00627458
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Jarvenpaa, Finland
- GSK Investigational Site Oulu, Finland
- GSK Investigational Site Pori, Finland
- GSK Investigational Site Tampere, Finland